MedTrace Logo

Use of the Modified PUQE Score on Admitted Cases of Hyperemesis Gravidarum (HG) to Guide Response to Treatment

NCT04785911 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-04-05

No results posted yet for this study

Summary

Use of the PUQE score to judge the need for admission in cases of hyperemesis gravidarum Evaluation of the response to treatment by the PUQE score

Conditions

  • Hyperemesis Gravidarum

Interventions

DRUG

Antiemetic Combinations

Evaluation of response to treatment of hyperemisis gravidarum (antiemetics and other methods ) by PUQE score

Sponsors & Collaborators

  • Assiut University

    collaborator OTHER

  • Tasnem Abo-elouon

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
46 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-05
Primary Completion
2022-10-01
Completion
2022-11-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04785911 on ClinicalTrials.gov